QBIO (Q BioMed) Cyclically Adjusted PB Ratio: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Q BioMed Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Q BioMed  (OTCPK:QBIO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Q BioMed Cyclically Adjusted PB Ratio Related Terms


Q BioMed Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Q BioMed's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q BioMed Cyclically Adjusted PB Ratio Chart

Q BioMed Annual Data
Trend Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Q BioMed Quarterly Data
May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

QBIO vs RGMP, CALA, PPCB: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Q BioMed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q BioMed Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q BioMed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Q BioMed's Cyclically Adjusted PB Ratio falls into.



Q BioMed Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Q BioMed's Cyclically Adjusted Book per Share for the fiscal year that ended in Nov22 is calculated as:

For example, Q BioMed's adjusted Book Value per Share data for the fiscal year that ended in Nov22 was:

Adj_Book=Book Value per Share/CPI of Nov22 (Change)*Current CPI (Nov22)
=-0.115/297.7110*297.7110
=-0.115

Current CPI (Nov22) = 297.7110.

Q BioMed Annual Data

Book Value per Share CPI Adj_Book
201311 0.003 233.069 0.004
201411 0.001 236.151 0.001
201511 -0.030 237.336 -0.038
201611 -0.221 241.353 -0.273
201711 0.029 246.669 0.035
201811 -0.007 252.038 -0.008
201911 -0.256 257.208 -0.296
202011 -0.345 260.229 -0.395
202111 -0.376 277.948 -0.403
202211 -0.115 297.711 -0.115

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Q BioMed Business Description

Address c/o Ortoli Rosenstadt LLP, 366 Madison Avenue, 3rd Floor, New York, NY, USA, 10017
Q BioMed Inc is a biotech acceleration and commercial stage company. It is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The company provides these target assets the strategic resources, developmental support, and expansion capital needed to ensure customers meet their developmental potential, enabling them to provide products to patients in need.